Clinical Trials Logo

Clinical Trial Summary

This is a Phase I, single-site study to evaluate the sensitization potential of topically applied ATx201 GEL, 2% and 4%, along with a placebo control, in healthy human subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03375957
Study type Interventional
Source AntibioTx A/S
Contact
Status Completed
Phase Phase 1
Start date January 8, 2018
Completion date March 15, 2018

See also
  Status Clinical Trial Phase
Completed NCT04332445 - Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity. N/A
Completed NCT05508243 - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray N/A
Completed NCT05508230 - Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products) N/A
Completed NCT04248556 - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization N/A
Completed NCT04250623 - Dermatological Assessment of Photoallergy and Phototoxicity N/A